Safety and immunogenicity evaluation of inactivated whole-virus-SARS-COV-2 as emerging vaccine development in Egypt
- Citation:
- Saleh, A. A., M. Asaad, I. Ryan, M. Amin, M. I. Shindy, W. A. Hassan, M. Samir, A. A. Khattab, S. S. Abdelgayed, M. G. Seadawy, et al., "Safety and immunogenicity evaluation of inactivated whole-virus-SARS-COV-2 as emerging vaccine development in Egypt", Antibody Therapeutics, vol. 4, issue 3, pp. 135-143, 2021.